Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propranolol in Acute Ischemic Stroke
NCT01061190Phase 3Completed
- Start
- Jan 2010
- Primary completion
- Oct 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in ischemic stroke comparing Propranolol with Placebo (2 arms). Primary endpoint: Composite incidence of cardiovascular and/or neurological complications including vascular death at 90 days. Started Jan 2010; status: completed.
02
Drugs
propranolol
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT01061190.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01061190.